UBS Lux Equity Fund Biotech USD vs Allianz US High Yield AM

UBS Lux Equity Fund Biotech USD vs Allianz US High Yield AM

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Allianz US High Yield AM

  • Security

    Allianz US High Yield AM USD

  • Fee

    1.24%

  • ISIN

    LU0516397667

  • Holdings

    5

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Allianz US High Yield AM, we have 5 holdings where CCF Holdings is the largest holding (2.69), followed by CCO Holdings LLC (2.2) and Iron Mountain (2.06).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Allianz US High Yield AM.

UBS Lux Equity Fund Biotech USD Allianz US High Yield AM
1. Regeneron Pharmaceuticals Inc
10.04 %
1. CCF Holdings LLC
USA
2.69 %
2. Moderna Inc
9.21 %
2. CCO Holdings LLC
USA
2.2 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Iron Mountain Inc
USA
2.06 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Caesars Entertainment Inc
1.4 %
5. AbbVie Inc
USA
4.91 %
5. Bombardier Inc Pref
1.32 %
6. Gilead Sciences Inc
USA
4.66 %
-
7. Amgen Inc
USA
4.43 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-

The list of fund holdings was last updated on July 25, 2025.